There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Edinburgh and its institutions have been at heart of the Union since it came about in 1707, here we look at the city's history.
In Berwick-upon-Tweed - the town at the northern-most tip of England - history has taught them that no border necessarily lasts forever.
His car was about to get towed away. But he had other ideas.